拉莫三嗪诱发的伴有口腔黏膜紫癜性损害的药物超敏反应综合征。 - Suppr

Suppr

超能文献

Lamotrigine-induced DRESS with purpuric lesions in the oral mucosa.

作者信息

Bozca Burçin Cansu, Unal Betül, Alpsoy Erkan

机构信息

Department of Dermatology and Venerology, Akdeniz University School of Medicine, Antalya, Turkey.

Department of Pathology, Akdeniz University School of Medicine, Antalya, Turkey.

出版信息

JAAD Case Rep. 2020 Apr 23;6(5):383-385. doi: 10.1016/j.jdcr.2019.09.012. eCollection 2020 May.

DOI:10.1016/j.jdcr.2019.09.012

PMID:32382623

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7200190/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89df/7200190/a0197b2ef2a9/gr1.jpg

相似文献

Lamotrigine-induced DRESS with purpuric lesions in the oral mucosa.

JAAD Case Rep. 2020 Apr 23;6(5):383-385. doi: 10.1016/j.jdcr.2019.09.012. eCollection 2020 May.

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.

J Dermatol. 2019 Mar;46(3):226-233. doi: 10.1111/1346-8138.14776. Epub 2019 Jan 21.

First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.

Ann Pharmacother. 2010 Dec;44(12):1998-2000. doi: 10.1345/aph.1P350. Epub 2010 Nov 23.

A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms.

Psychiatr Pol. 2017 Dec 30;51(6):1079-1093. doi: 10.12740/PP/74358.

Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.

Pharmacotherapy. 2015 Mar;35(3):e9-e12. doi: 10.1002/phar.1550. Epub 2015 Mar 10.

Dress syndrome and fulminant hepatic failure induced by lamotrigine.

Ann Hepatol. 2009 Jan-Mar;8(1):75-7.

Lamotrigine-induced DRESS Syndrome Manifesting as 'Eosinophilic Colitis': An Uncommon Presentation of a Very Uncommon Condition.

Cureus. 2020 Apr 7;12(4):e7570. doi: 10.7759/cureus.7570.

Lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) during primary Epstein-Barr virus (EBV) infection.

BMJ Case Rep. 2018 Jan 23;2018:bcr-2017-222416. doi: 10.1136/bcr-2017-222416.

Lamotrigine-induced Hypersensitivity Syndrome with Histologic Features of CD30+ Lymphoma.

Indian J Dermatol. 2016 Mar-Apr;61(2):235. doi: 10.4103/0019-5154.177784.

Drug Reaction with Eosinophilia and Systemic Symptom Syndrome Induced by Lamotrigine.

Ann Dermatol. 2017 Apr;29(2):206-209. doi: 10.5021/ad.2017.29.2.206. Epub 2017 Mar 24.

引用本文的文献

Evaluation of Anticonvulsant-Induced Leukocytosis: A Review of Evidence for Carbamazepine, Lamotrigine, and Phenobarbital.

J Pharm Technol. 2024 Jun;40(3):158-165. doi: 10.1177/87551225241228100. Epub 2024 Jan 31.

本文引用的文献

Lamotrigine induced DIHS/DRESS: Manifestations, treatment, and outcome in 57 patients.

Clin Neurol Neurosurg. 2015 Nov;138:1-7. doi: 10.1016/j.clineuro.2015.07.008. Epub 2015 Jul 8.

Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.

Pharmacotherapy. 2015 Mar;35(3):e9-e12. doi: 10.1002/phar.1550. Epub 2015 Mar 10.

DRESS syndrome: Part I. Clinical perspectives.

J Am Acad Dermatol. 2013 May;68(5):693.e1-14; quiz 706-8. doi: 10.1016/j.jaad.2013.01.033.

Endothelial damage in all types of T-lymphocyte-mediated drug-induced eruptions.

Arch Dermatol. 2011 May;147(5):579-84. doi: 10.1001/archdermatol.2011.104.

Localized purpura associated with lamotrigine.

Pediatr Neurol. 2006 Sep;35(3):227-8. doi: 10.1016/j.pediatrneurol.2006.02.015.

Lamotrigine-associated rash: risk/benefit considerations in adults and children.

Epilepsia. 1999 Jul;40(7):985-91. doi: 10.1111/j.1528-1157.1999.tb00807.x.

Antiepileptic drug hypersensitivity syndrome.

Epilepsia. 1998;39 Suppl 7:S3-7. doi: 10.1111/j.1528-1157.1998.tb01678.x.

A mechanistic approach to antiepileptic drug interactions.

Ann Pharmacother. 1998 May;32(5):554-63. doi: 10.1345/aph.17332.

Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy.

Epilepsy Res. 1994 Oct;19(2):123-7. doi: 10.1016/0920-1211(94)90022-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Lamotrigine-induced DRESS with purpuric lesions in the oral mucosa.

作者信息

Bozca Burçin Cansu, Unal Betül, Alpsoy Erkan

机构信息

Department of Dermatology and Venerology, Akdeniz University School of Medicine, Antalya, Turkey.

Department of Pathology, Akdeniz University School of Medicine, Antalya, Turkey.

出版信息

JAAD Case Rep. 2020 Apr 23;6(5):383-385. doi: 10.1016/j.jdcr.2019.09.012. eCollection 2020 May.

DOI:10.1016/j.jdcr.2019.09.012

PMID:32382623

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7200190/

Abstract

摘要

相似文献

Lamotrigine-induced DRESS with purpuric lesions in the oral mucosa.

JAAD Case Rep. 2020 Apr 23;6(5):383-385. doi: 10.1016/j.jdcr.2019.09.012. eCollection 2020 May.

Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.

J Dermatol. 2019 Mar;46(3):226-233. doi: 10.1111/1346-8138.14776. Epub 2019 Jan 21.

First report of lamotrigine-induced drug rash with eosinophilia and systemic symptoms syndrome with pancreatitis.

Ann Pharmacother. 2010 Dec;44(12):1998-2000. doi: 10.1345/aph.1P350. Epub 2010 Nov 23.

A retrospective study of DRESS - drug reaction with eosinophilia and systemic symptoms.

Psychiatr Pol. 2017 Dec 30;51(6):1079-1093. doi: 10.12740/PP/74358.

Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.

Pharmacotherapy. 2015 Mar;35(3):e9-e12. doi: 10.1002/phar.1550. Epub 2015 Mar 10.

Dress syndrome and fulminant hepatic failure induced by lamotrigine.

Ann Hepatol. 2009 Jan-Mar;8(1):75-7.

Lamotrigine-induced DRESS Syndrome Manifesting as 'Eosinophilic Colitis': An Uncommon Presentation of a Very Uncommon Condition.

Cureus. 2020 Apr 7;12(4):e7570. doi: 10.7759/cureus.7570.

Lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) during primary Epstein-Barr virus (EBV) infection.

BMJ Case Rep. 2018 Jan 23;2018:bcr-2017-222416. doi: 10.1136/bcr-2017-222416.

Lamotrigine-induced Hypersensitivity Syndrome with Histologic Features of CD30+ Lymphoma.

Indian J Dermatol. 2016 Mar-Apr;61(2):235. doi: 10.4103/0019-5154.177784.

Drug Reaction with Eosinophilia and Systemic Symptom Syndrome Induced by Lamotrigine.

Ann Dermatol. 2017 Apr;29(2):206-209. doi: 10.5021/ad.2017.29.2.206. Epub 2017 Mar 24.

引用本文的文献

Evaluation of Anticonvulsant-Induced Leukocytosis: A Review of Evidence for Carbamazepine, Lamotrigine, and Phenobarbital.

J Pharm Technol. 2024 Jun;40(3):158-165. doi: 10.1177/87551225241228100. Epub 2024 Jan 31.

本文引用的文献

Lamotrigine induced DIHS/DRESS: Manifestations, treatment, and outcome in 57 patients.

Clin Neurol Neurosurg. 2015 Nov;138:1-7. doi: 10.1016/j.clineuro.2015.07.008. Epub 2015 Jul 8.

Drug reaction with eosinophilia and systemic symptoms syndrome probably induced by a lamotrigine-ginseng drug interaction.

Pharmacotherapy. 2015 Mar;35(3):e9-e12. doi: 10.1002/phar.1550. Epub 2015 Mar 10.

DRESS syndrome: Part I. Clinical perspectives.

J Am Acad Dermatol. 2013 May;68(5):693.e1-14; quiz 706-8. doi: 10.1016/j.jaad.2013.01.033.

Endothelial damage in all types of T-lymphocyte-mediated drug-induced eruptions.

Arch Dermatol. 2011 May;147(5):579-84. doi: 10.1001/archdermatol.2011.104.

Localized purpura associated with lamotrigine.

Pediatr Neurol. 2006 Sep;35(3):227-8. doi: 10.1016/j.pediatrneurol.2006.02.015.

Lamotrigine-associated rash: risk/benefit considerations in adults and children.

Epilepsia. 1999 Jul;40(7):985-91. doi: 10.1111/j.1528-1157.1999.tb00807.x.

Antiepileptic drug hypersensitivity syndrome.

Epilepsia. 1998;39 Suppl 7:S3-7. doi: 10.1111/j.1528-1157.1998.tb01678.x.

A mechanistic approach to antiepileptic drug interactions.

Ann Pharmacother. 1998 May;32(5):554-63. doi: 10.1345/aph.17332.

Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy.

Epilepsy Res. 1994 Oct;19(2):123-7. doi: 10.1016/0920-1211(94)90022-1.